Cargando…
Flow-Mediated Dilation, a Marker of Endothelial Cell Dysfunction, in Patients with Pulmonary Hypertension
BACKGROUND: Flow-mediated dilation (FMD) is considered a marker of endothelial cell dysfunction (ECD) and has been mostly evaluated in coronary artery disease. The role of ECD in the pathogenesis of pulmonary hypertension (PH) is not well-known. This study sought to evaluate the relationship between...
Autores principales: | Mirdamadi, Ahmad, Shirzad, Mohammad, Abrishamkar, Raana, Behjati, Mohaddeseh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577205/ https://www.ncbi.nlm.nih.gov/pubmed/36267930 |
Ejemplares similares
-
Role of Meticulous Observation: Successful Pregnancy in a 30-Year-Old Woman with Severe Pulmonary Hypertension
por: Mirdamadi, Ahmad, et al.
Publicado: (2016) -
Comparing outcomes of clonidine and captopril in patients with hypertensive urgency: A randomized clinical trial
por: Mirdamadi, Ahmad, et al.
Publicado: (2022) -
Severe mitral regurgitation, an unusual manifestation of chemotherapy-induced cardiotoxicity
por: Mirdamadi, Ahmad, et al.
Publicado: (2017) -
Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders
por: Yildiz, Abdulkerim, et al.
Publicado: (2018) -
Visfatin versus Flow-Mediated Dilatation as a Marker of Endothelial Dysfunction in Pediatric Renal Transplant Recipients
por: Fadel, Fatina, et al.
Publicado: (2017)